The PSC-Derived Therapies Symposium, hosted by the International Society for Stem Cell Research (ISSCR), aims to accelerate the development of therapies derived from pluripotent stem cells (PSC-derived cell therapies) by reversing the conventional “bench-to-bedside” model. Attendees will start with the ultimate goal—a successful cell therapy—and work backward through the development pipeline. ISSCR will bring together academic researchers, industry scientists, clinicians, regulators, manufacturers, and investors to explore clinical-trial progress, manufacturing hurdles, next-generation platforms, technology innovations, and patient perspectives in PSC-derived therapeutics.

Date/Time: 9:00 am ET, December 11, 2025 – 5:30 pm ET, December 12, 2025
Location: Hyatt Regency Boston Cambridge, Cambridge, MA

JOIN US!

Looking for a reliable partner to accelerate iPSC therapies to patients?

Meet us at the 2025 Boston International Symposium to learn how Catalent helps early-stage developers bring iPSC therapies to the clinic faster through flexible, tailored partnerships.

Don’t forget to connect with our iPSC expert Frederic Cedrone to discuss your iPSC programs. Frederic will be there to do an innovation showcase presentation and talk more about Catalent’s iPSC expertise.

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Innovation showcase presentation
Speaker: Frederic Cedrone, Ph.D., Vice President Corporate Innovation, Catalent
Date/Time: 8:50 – 9:10 AM, Dec 12, 2025
Title: Compliance by Design: Lessons from creating GMP iPSCs for cell therapies and patient cures

Invited panelist: Frederic Cedrone, Ph.D., Vice President Corporate Innovation, Catalent
Panel discussion title: I Wish I Would Have: Lessons Learned in Product Development
Date/Time: 9:35-10:30 AM, Dec 12, 2025

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™